Clinical Trials Browser

Interventional × Prostatic Neoplasms × montanide ISA 51 × Clear all

NCT02452307 2017-08-17

Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy

Phase 1/2 Unknown

Prostatic Neoplasms

NCT00109811 2013-01-23

Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms